Core Viewpoint - The announcement by Tianfu (03759) highlights the requirement for Taiwanese investors to obtain approval from the Taiwan Investment Commission for direct or indirect investments in China through their controlled companies [1][2]. Group 1: Investment Regulations - Taiwanese investors, including individuals and enterprises, must seek prior approval from the Taiwan Investment Commission for investments in China [1]. - If the total investment by all Taiwanese investors in a single Chinese entity does not exceed 1 million USD, they can submit a post-investment report to the Taiwan Investment Commission within six months after the investment [1][2]. Group 2: Company Compliance - The company has multiple Taiwanese founders and original investors who must comply with the aforementioned investment regulations when injecting proceeds from their Hong Kong listing into the company's Chinese subsidiary [1]. - The company confirms that it will fully comply with the investment regulations during the period from July 1, 2025, to December 31, 2025, without injecting listing proceeds into the Chinese subsidiary [2].

Core Viewpoint - The announcement from Tianfu (03759) highlights the requirement for Taiwanese investors to obtain approval from the Taiwan Investment Commission for direct or indirect investments in China through their controlled companies [1][2]. Group 1: Investment Regulations - Taiwanese investors, including individuals and enterprises, must seek prior approval from the Taiwan Investment Commission for investments in China [1]. - If the total investment in a single Chinese entity by Taiwanese investors does not exceed 1 million USD, they are allowed to submit a post-investment report to the Taiwan Investment Commission within six months after the investment [1][2]. Group 2: Company Compliance - The company has multiple Taiwanese founders and 81 original Taiwanese investors who must comply with the aforementioned cross-strait investment regulations when injecting funds from the Hong Kong IPO into its Chinese subsidiaries [1]. - The company confirms that it will fully comply with the cross-strait investment regulations during the period from July 1, 2025, to December 31, 2025, and will not inject IPO proceeds into its Chinese subsidiaries during this timeframe [2].